Menopause Launch Sends Hims & Hers (HIMS) Stock Soaring – What’s Next?
On Oct. 15, Hims & Hers stunned the market by launching a dedicated menopause/perimenopause care program on its “Hers” telehealth platform. The company said the new service would connect women with personalized hormone therapies to ease symptoms like hot flashes and sleep issuests2.tech. This push into a historically underserved sector met eager investor demand. As Benzinga and TS2.tech reported, HIMS stock raced +10–13% that day, trading near $60 with extremely heavy volumets2.tech. By the close, HIMS was up roughly +16%, a one-day gain not seen in monthsts2.techts2.tech.
